A Retrospective Study of Clinical Pathways and Outcomes of Andexanet Alfa Administration for Reversal of Critical Bleeding or Urgent Surgery in Patients on Oral Direct Factor Xa Inhibitors

被引：0
|
作者：
Goldin, Mark
Smith, Kolton
Koulas, Ioannis
Leung, Tung Ming
Ravi, Mayuri
Parhar, Sanjit
Shah, Sejal
Floyd, Kayla
Ohanesian, Lori
Bain, Rachel
Defonte, Daniella
Ochani, Kanta
Spyropoulos, Alex
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Anticoagulation; Thrombosis; Vascular; Progenitor cell;
D O I：
10.1161/circ.148.suppl_1.15557
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A15557
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Efficacy and Safety of Direct Oral Factor Xa Inhibitors in Patients after Bariatric Surgery
    Kushnir, Margarita
    Gali, Radhika
    Alexander, Mariam
    Billett, Henny Heisler H.
    BLOOD, 2019, 134
  • [22] Real-world clinical outcomes among US Veterans with oral factor xa inhibitor–related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate
    S. Scott Sutton
    Joseph Magagnoli
    Tammy H. Cummings
    Theresa Dettling
    Belinda Lovelace
    Mary J. Christoph
    James W. Hardin
    Journal of Thrombosis and Thrombolysis, 2023, 56 : 137 - 146
  • [23] The Efficacy and Safety of Andexanet Alfa in Patients With Acute Gastrointestinal Bleeding While Taking Factor Xa Inhibitors: An ANNEXA-4 Sub-Analysis
    Siegal, Deborah
    Beyer-Westendorf, Jan
    Yue, Patrick
    Souza, Sonia
    Nakamya, Juliet
    Connolly, Stuart J.
    Crowther, Mark
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S332 - S333
  • [24] Real-world clinical outcomes among US Veterans with oral factor xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate
    Sutton, S. Scott
    Magagnoli, Joseph
    Cummings, Tammy H.
    Dettling, Theresa
    Lovelace, Belinda
    Christoph, Mary J.
    Hardin, James W.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2023, 56 (01) : 137 - 146
  • [25] REAL-WORLD CLINICAL OUTCOMES AMONG US VETERANS WITH ORAL FACTOR XA INHIBITOR-RELATED MAJOR BLEEDING TREATED WITH ANDEXANET ALFA OR 4-FACTOR PROTHROMBIN COMPLEX CONCENTRATE
    Sutton, S. Scott
    Magagnoli, Joe
    Cummings, Tammy H.
    Dettling, Terry
    Hardin, James
    Lovelace, Belinda
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : E107 - E108
  • [26] Evidence-Based Minireview: Mortality and thrombosis in patients receiving prothrombin complex concentrates or andexanet alfa for the management of direct oral factor Xa inhibitor-associated major bleeding
    Kimpton, Miriam
    Siegal, Deborah M.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2019, : 204 - 208
  • [27] Clinical Course of Intracranial Bleeding in Patients Anticoagulated With Factor Xa inhibitors Without the Use of Specific Reversal Agents
    Nelton, Emmalin
    Maragkos, Georgios
    Richter, Sven
    Filippidis, Aristotelis
    Stippler, Martina
    NEUROSURGERY, 2019, 66 : 178 - 178
  • [28] Correction to: Real-world clinical outcomes among US Veterans with oral factor xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate
    S. Scott Sutton
    Joseph Magagnoli
    Tammy H. Cummings
    Theresa Dettling
    Belinda Lovelace
    Mary J. Christoph
    James W. Hardin
    Journal of Thrombosis and Thrombolysis, 2023, 56 : 360 - 360
  • [29] A RETROSPECTIVE CHART REVIEW TO EVALUATE 4-FACTOR PROTHROMBIN COMPLEX CONCENTRATES FOR THE REVERSAL OF FACTOR XA INHIBITORS BEFORE SURGERY OR MAJOR BLEEDING
    Grottke, O.
    Ay, H.
    Kokot-Kierepa, M.
    Romanus, D.
    HAEMOPHILIA, 2023, 29 : 207 - 207
  • [30] Enoxaparin is not an oral factor Xa inhibitor. Response to Sutton et al. real-world clinical outcomes among US veterans with oral factor Xa inhibitor–related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate
    Richard J Buka
    David J Sutton
    Phillip LR Nicolson
    Journal of Thrombosis and Thrombolysis, 2024, 57 : 739 - 741
12345